Clinical Trial Update: Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

This document reports a completed double-blind, placebo-controlled Phase 2/3 trial comparing omeprazole to fluoxetine for non-erosive reflux disease and its sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• Fluoxetine (Fluoxetine)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Non-erosive Reflux Disease | Phase 2, Phase 3 | Status: COMPLETED